Hemostatic Disorders  >>  Bayer  >>  Phase 3
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials		 02468101214161820
            
            
             
Campath (alemtuzumab) / Sanofi           
          
            
             
Kovaltry (octocog alfa) / Bayer, CSL Behring           
          
            
             
Gamunex (intravenous normal human immunoglobulin 10%) / Bayer, Grifols, Kedrion           
          
            
             
Jivi (damoctocog alfa pegol) / Bayer           
          
            
             
long-acting sequence-modified recombinant factor VIIa (BAY 866150) / Bayer